Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-231.11%EBITDA Margin
VS
Market
Sector
Industry
History
$ 9.84Close
$ 5.54 - $ 18.57 52-Week Range
Ticker Information
Ticker
KURACompany Name
KURA ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQKURA ONCOLOGY INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
KURA - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -192.46M | -231.11% | $ 83.28M |
| 3/31/2025 | $ -177.19M | -260.6% | $ 67.99M |
| 12/31/2024 | $ -169.5M | -314.57% | $ 53.88M |
| 9/30/2024 | $ -195.08M | 0% | $ 0 |
| 6/30/2024 | $ -179.28M | 0% | $ 0 |
| 3/31/2024 | $ -165.63M | 0% | $ 0 |
| 12/31/2023 | $ -150.23M | 0% | $ 0 |
| 9/30/2023 | $ -140.73M | 0% | $ 0 |
| 6/30/2023 | $ -138.06M | 0% | $ 0 |
| 3/31/2023 | $ -136.07M | 0% | $ 0 |
Key Performance Insights, Last 5 Years
- KURA ONCOLOGY INC's latest trailing twelve months (TTM) EBITDA % stands at 0%.
- Over the past 5 years, KURA ONCOLOGY INC's average EBITDA % has been -268.76%.
- The median EBITDA % for KURA ONCOLOGY INC during this period was -260.6%
- KURA ONCOLOGY INC reached its highest EBITDA % over the past 5 years at -231.11%.
- The lowest EBITDA % recorded by KURA ONCOLOGY INC in the same timeframe -314.57%
KURA ONCOLOGY INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for KURA ONCOLOGY INC is calculated as follows: EBITDA [ $ -80.67M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ] KURA - EBITDA Margin, Last 5 years
-314.57%
Minimum
Dec 31, 2024
-231.11%
Maximum
Jun 30, 2025
-268.76%
Average
-260.6%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -75.07% |
| max | 97.73% |
| average | 16.12% |
| median | 14.72% |
| std | 26.88% |